Cargando…

Phenotypic heterogeneity in females with X-linked Alport syndrome

Aims: X-linked Alport syndrome (AS) is a monogenic inherited disorder of type IV collagen, a structural protein in the kidney and cochlea. Males typically exhibit a severe phenotype with end-stage renal disease (ESRD) and/or deafness by early adulthood. Because of the presence of two X chromosomes,...

Descripción completa

Detalles Bibliográficos
Autores principales: Allred, Samuel C., Weck, Karen E., Gasim, Adil, Mottl, Amy K.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dustri-Verlag Dr. Karl Feistle 2015
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4928029/
https://www.ncbi.nlm.nih.gov/pubmed/26249550
http://dx.doi.org/10.5414/CN108561
_version_ 1782440361635872768
author Allred, Samuel C.
Weck, Karen E.
Gasim, Adil
Mottl, Amy K.
author_facet Allred, Samuel C.
Weck, Karen E.
Gasim, Adil
Mottl, Amy K.
author_sort Allred, Samuel C.
collection PubMed
description Aims: X-linked Alport syndrome (AS) is a monogenic inherited disorder of type IV collagen, a structural protein in the kidney and cochlea. Males typically exhibit a severe phenotype with end-stage renal disease (ESRD) and/or deafness by early adulthood. Because of the presence of two X chromosomes, females often have a less severe phenotype and hence the diagnosis of AS is often not considered. Herein, we present a case of an adolescent girl with proteinuria and hematuria in the setting of a strong family history of AL. Case report: The mother and maternal aunt of the proband had both presented with dipstick positive hematuria and proteinuria at age 8 years. These girls were not evaluated by nephrology until mid-adolescence when they had worsening creatinine levels. Kidney biopsy in the younger sister demonstrated segmental glomerulosclerosis with segmental thinning and lamination of the glomerular basement membrane, consistent with AS. Kidney biopsy in the older sister was performed just prior to the need for renal replacement therapy and showed only global glomerulosclerosis. Both sisters were transplanted by the age of 20 years. Their mother subsequently developed ESRD at age 53 years. With the advent of genetic testing, the proband and her family were brought in for evaluation. It had been assumed this family of AS had autosomal dominant transmission, however, genetic testing of the proband was positive for a splice site mutation of COL4A5 located on the X-chromosome. Sequencing of genes COL4A3, COL4A4, and COL4A6 were negative for mutation. Conclusions: The current case report demonstrates the importance of considering skewed X-inactivation in females who exhibit signs or symptoms of X-linked disorders.
format Online
Article
Text
id pubmed-4928029
institution National Center for Biotechnology Information
language English
publishDate 2015
publisher Dustri-Verlag Dr. Karl Feistle
record_format MEDLINE/PubMed
spelling pubmed-49280292016-07-14 Phenotypic heterogeneity in females with X-linked Alport syndrome Allred, Samuel C. Weck, Karen E. Gasim, Adil Mottl, Amy K. Clin Nephrol Case Report Aims: X-linked Alport syndrome (AS) is a monogenic inherited disorder of type IV collagen, a structural protein in the kidney and cochlea. Males typically exhibit a severe phenotype with end-stage renal disease (ESRD) and/or deafness by early adulthood. Because of the presence of two X chromosomes, females often have a less severe phenotype and hence the diagnosis of AS is often not considered. Herein, we present a case of an adolescent girl with proteinuria and hematuria in the setting of a strong family history of AL. Case report: The mother and maternal aunt of the proband had both presented with dipstick positive hematuria and proteinuria at age 8 years. These girls were not evaluated by nephrology until mid-adolescence when they had worsening creatinine levels. Kidney biopsy in the younger sister demonstrated segmental glomerulosclerosis with segmental thinning and lamination of the glomerular basement membrane, consistent with AS. Kidney biopsy in the older sister was performed just prior to the need for renal replacement therapy and showed only global glomerulosclerosis. Both sisters were transplanted by the age of 20 years. Their mother subsequently developed ESRD at age 53 years. With the advent of genetic testing, the proband and her family were brought in for evaluation. It had been assumed this family of AS had autosomal dominant transmission, however, genetic testing of the proband was positive for a splice site mutation of COL4A5 located on the X-chromosome. Sequencing of genes COL4A3, COL4A4, and COL4A6 were negative for mutation. Conclusions: The current case report demonstrates the importance of considering skewed X-inactivation in females who exhibit signs or symptoms of X-linked disorders. Dustri-Verlag Dr. Karl Feistle 2015-11 2015-08-07 /pmc/articles/PMC4928029/ /pubmed/26249550 http://dx.doi.org/10.5414/CN108561 Text en © Dustri-Verlag Dr. K. Feistle http://creativecommons.org/licenses/by/2.5/ This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Case Report
Allred, Samuel C.
Weck, Karen E.
Gasim, Adil
Mottl, Amy K.
Phenotypic heterogeneity in females with X-linked Alport syndrome
title Phenotypic heterogeneity in females with X-linked Alport syndrome
title_full Phenotypic heterogeneity in females with X-linked Alport syndrome
title_fullStr Phenotypic heterogeneity in females with X-linked Alport syndrome
title_full_unstemmed Phenotypic heterogeneity in females with X-linked Alport syndrome
title_short Phenotypic heterogeneity in females with X-linked Alport syndrome
title_sort phenotypic heterogeneity in females with x-linked alport syndrome
topic Case Report
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4928029/
https://www.ncbi.nlm.nih.gov/pubmed/26249550
http://dx.doi.org/10.5414/CN108561
work_keys_str_mv AT allredsamuelc phenotypicheterogeneityinfemaleswithxlinkedalportsyndrome
AT weckkarene phenotypicheterogeneityinfemaleswithxlinkedalportsyndrome
AT gasimadil phenotypicheterogeneityinfemaleswithxlinkedalportsyndrome
AT mottlamyk phenotypicheterogeneityinfemaleswithxlinkedalportsyndrome